Combination HIV therapy no risk to fetus
21 June 2002
Women who take combination antiretroviral therapy for HIV while pregnant do not seem to have more adverse birth outcomes, say US researchers.
Compared with women who did not use anti-retroviral therapy, or used monotherapy, combination therapy was not associated with premature delivery, low birth-weight, low Agpar scores or stillbirth.
'Our data provide reassurance that the risks of adverse outcomes of pregnancy that are attributable to anti-retroviral therapy are low and are likely to be outweighed by the recognised benefits of such therapy during pregnancy,' researchers wrote in the New England Journal of Medicine (2002; 346: 1863-70).
Last Reviewed: 24 June 2002
- 1. Medical Observer Weekly 21/6/02
Sponsored links
